Skip to content
Contact Us
shutterstock_2154471629 shutterstock_2154471629

Clinical Trial Project Management

Elevate your research with Precision, where every detail is meticulously managed.
At the heart of breakthrough clinical research lies unmatched project management. Discover how Precision for Medicine's approach transforms challenges into triumphs, ensuring your trial's precision from start to finish. Leveraging deep industry knowledge and cutting-edge technology, we are committed to propelling your research forward, delivering impactful therapies to patients who need them most.
# 611310815 Adobe Stock

Innovative research requires innovative project managers

Precision is not just part of our name; it defines our approach to clinical trial project management and execution. Our Project Managers, each bringing an average of 13 years of experience, embody this precision. Their innovative problem-solving and agility is critical to keeping your clinical trial on track. By aligning closely with our sponsors, we help navigate the ever changing landscape at the forefront of research, particularly in groundbreaking areas like Oncology and Rare Diseases. Our expertise is not just about managing trials but pioneering new processes and solutions alongside those we serve, ensuring each study is executed with unmatched precision, creativity and insight. 

Our dedication to excellence and innovation sets us apart, making Precision a pivotal partner in our sponsors' quests for medical breakthroughs. Our specialized team, deeply experienced in Oncology and Rare Diseases, seamlessly turns ambitious visions into realities. This commitment not only differentiates us in the industry but also marks both our paths with lasting impacts on science and patient care.

Precision Project Management: From strategy to success

Begin your clinical trial journey with project managers who prioritize precision, from initial strategy to final analysis. Our partnership is built on a foundation of dedication, expertise, and an uncompromising commitment to patient safety and data integrity.

  • Strategize

    Strategize

    Plan & Design with Precision

    Begin with a strong foundation as our Project Managers synthesize your objectives into a robust Project Management Plan. They ensure meticulous timelines and incorporate safeguards and contingencies, crafting a roadmap tailored for success.

  • Execute

    Execute

    Initiate & Maintain Alignment with Precision

    The journey from planning to action is seamless under our Project Managers' watchful guidance. They work closely with the Precision team to deliver on-time site activation and maintain alignment across all stakeholders, orchestrating cohesion and clarity across all stages of your clinical study.

  • Monitor

    Monitor

    Monitor, Advise & Report with Precision

    Our Project Managers, as an extension of your team, not only oversee the trial's progress but ensure operational excellence. They leverage real-time data and proactive strategies to uphold safety and quality, providing timely advice and comprehensive reports.

  • Deliver

    Deliver

    Finish with Precision

    Your trial concludes with the same detail-oriented precision that it began, culminating in a comprehensive clinical study report and a meticulously maintained trial master file. Every insight gained is poised to enrich your future research.
Clinical Trial Project Manager_at front-v2

Guiding your trials with Precision Principles

Our approach to Clinical Trial Project Management is rooted deeply in the Precision Principles that define our corporate ethos. We view our clients as partners, ensuring that every aspect of our service is delivered with quality, creativity, and innovation. Our team embodies passion and purpose, holding themselves accountable while fostering an environment of mutual respect. Collaboration is key — we work hand-in-hand with you, ensuring integrity and transparency lead our combined efforts. This partnership ethos extends beyond mere collaboration; it is a commitment to shared success, driving forward with mutual goals, and celebrating every milestone in our quest to transform patient lives through groundbreaking research.

Explore our Principles

Propel your therapy from early insight to late phase impact

  • Discover Early Phase Excellence
    Early Phase Patient

    Early Phase Excellence

    Navigate the complexities of early clinical development with Precision's seasoned Project Managers, where strategic foresight meets diligent execution. Learn more about our early phase solutions.

    Explore
  • Discover Late Phase Success
    Late Phase Success

    Late Phase Success

    Chart your course to approval with late phase trial mastery, guided by our Project Managers' specialized expertise and operational acumen. Learn more about our late phase solutions.

    Explore

Pioneer new therapies with Precision expertise

Navigate our realm of therapeutic and modality expertise, where we propel your pioneering treatments in Oncology, Rare Diseases, and more, from concept to reality.

Oncology Explore Rare Diseases Explore Autoimmune Explore Gene Therapy Explore Cell Therapy Explore

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to accelerate speed to market. Precision can customize and converge our capabilities to meet your program's unique needs—driving efficiency, agility, and success from start to finish.

  • Discover Explore
    clinical-trial-support

    Global CRO Services

    A recognized leader in oncology and rare diseases with rich experience in complex trials

    Explore
  • Discover Explore
    specialty-lab-services

    Laboratory
    Services

    Experts in translational and biomarker sciences with worldwide specialty labs and central lab services that are enabling breakthroughs.

    Explore

Read the latest insights on Precision’s blog

Discover expert analysis and broaden your understanding through Precision’s Insights on current research, case studies, and trends. 

Explore our blog
Read: FDA's Vision for Multiregional Clinical Trials in Oncology FDA's Vision for Multiregional Clinical Trials in Oncology

Clinical Trials - Regulatory - Oncology

FDA's Vision for Multiregional Clinical Trials in Oncology

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=167363064857, hs_child_table_id=0, hs_updated_at=1719905898183, hs_published_at=1744844126301, description=Industry-leading oncologist and demonstrated medical leader in precision medicine, novel trial design and innovative regulatory initiatives designed to expedite drug approvals. Draws on nearly a decade leading oncology and rare disease programs at the FDA. Former fellow at the National Cancer Institute and frequent featured speaker at ASCO and AACR. CDER technical authority on oncologic drug and biological products for thoracic and head and neck malignancies, neurologic tumors, pediatric solid tumors and rare tumors., avatar=Image{width=553,height=580,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Harpreet-Singh2.png',altText='Harpreet-Singh2',fileId=171747124346}, linkedin=https://www.linkedin.com/in/harpreetsinghmd/, team=[{id=163072475007, name='Precision for Medicine Leadership'}], lastname=Singh, MD, hs_initial_published_at=1715692570942, hs_created_by_user_id=2737751, hs_created_at=1715692477118, hs_is_edited=false, hs_deleted_at=0, name=Harpreet, job=Chief Medical Officer, slug=harpreet-singh, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Harpreet Singh, MD avatar

    Harpreet Singh, MD
Discover
Read: Contract Research Organization vs Clinical Research Organization (CRO vs CRO) Contract Research Organization vs Clinical Research Organization (CRO vs CRO)

Clinical Trials

Contract Research Organization vs Clinical Research Organization (CRO vs CRO)

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778858, hs_child_table_id=0, hs_updated_at=1744830865620, hs_published_at=1744844126301, description=Rob Maiale is a marketing strategist and creative technologist with 17 years of experience turning complex ideas into growth. He currently leads content strategy, where he transforms insights from Precision experts into market-shaping narratives that drive the advancement of next-generation therapies.  Rob’s career spans journalism, advertising, and brand storytelling, with a through-line of making the meaningful memorable. His work blends creative strategy with emerging AI tools to help Precision stay ahead of the curve—and above the noise., avatar=Image{width=400,height=400,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Rob%20Maiale.jpg',altText='Rob Maiale',fileId=184765575245}, linkedin=https://www.linkedin.com/in/rob-maiale/, hs_name=, hs_path=, lastname=Maiale, hs_initial_published_at=1744843965759, hs_created_at=1709645745089, hs_is_edited=false, hs_deleted_at=0, name=Rob, position=Associate Director, Digital Content & Inbound Marketing, job=, slug=rob-maiale, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Rob Maiale avatar

    Rob Maiale
Discover
Read: The Amendment Trap: Why 76% of Clinical Trials Face Six-Figure Protocol Changes The Amendment Trap: Why 76% of Clinical Trials Face Six-Figure Protocol Changes

Clinical Trials

The Amendment Trap: Why 76% of Clinical Trials Face Six-Figure Protocol Changes

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=187570680222, hs_child_table_id=0, hs_updated_at=1742413198455, hs_published_at=1744844126301, description=Christine has been ensuring high performance delivery of clinical research projects for more than 23 years. During this time, she has successfully led diverse teams across various cancer indications including renal, pancreatic, melanoma, lung, head and neck, breast, multiple myeloma, extra-nodal NK/T lymphoma, non-Hodgkin’s lymphoma, and Hodgkin’s lymphoma. Within the CRO setting she also supported the strategic development of over 50 hematology/oncology programs including complex Phase 1 projects in immuno-oncology and autologous cell therapy. She also led the establishment of a novel oncology research infrastructure which accelerated study activations for Phase 1 solid tumor studies. Christine obtained her master’s degree in public health at the University of Texas where she also trained in the development and implementation of clinical and epidemiologic research at the Coordinating Center for Clinical Trials as well as the Center for Occupational and Environment Health., avatar=Image{width=1200,height=1200,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Christine%20Lusk-1.png',altText='Christine Lusk-1',fileId=187579105870}, lastname=Lusk, hs_initial_published_at=1742410730688, hs_created_by_user_id=26433386, hs_created_at=1742410650472, hs_is_edited=false, hs_deleted_at=0, name=Christine, job=Director, Project Management, slug=christine-lusk, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Christine Lusk avatar

    Christine Lusk
Discover